Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P533: Ustekinumab therapeutic drug monitoring in Crohn’s disease patients with loss of response

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Heron*1,2, T. Bessissow1, A. Bitton1, P. Lakatos1, E. Seidman1, A. Jain3, R. Battat1,4, P. Germain1, C. Lemieux1, W. Afif1

1McGill University Health Centre, Department of Gastroenterology, Montreal, Canada, 2Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, USA, 3Prometheus Laboratories Inc., San Diego, USA, 4University of California San Diego, Division of Gastroenterology, La Jolla, USA

P534: IBD-related malignancies observed in 2015–2018: 4 years’ results from the prospective nationwide Hungarian registry

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Milassin*1, M. Rutka1, K. Farkas1, A. Bálint1, R. Bor1, A. Fábián1, Z. Szepes1, T. Szamosi2, K. Szántó1, P. Miheller3, Z. Barta4, J. Banai2, Á. Kovács5, Á. Salamon6, L. Lakatos7, L. Lakner7, K. Palatka8, M. Papp9, E. Schafer2, J. Novák10, Z. Erdélyi11, Z. Kürti12, P. L. Lakatos12, P. Sarlós13, N. Szigeti14, G. Veres9, A. Zaránd16, A. Gelley17, Á. Vincze18, F. Nagy1, T. Molnár1

1University of Szeged, First Department of Internal Medicine, Szeged, Hungary, 2Military Hospital - State Health Centre, Budapest, Hungary, 3Semmelweis University, Second Department of Internal Medicine, Budapest, Hungary, 4University of Debrecen, Department of Gastroenterology, Department of Medicine, Clinical Centre, Debrecen, Hungary, 5Péterfi Sándor Utcai Hospital Centre, Budapest, Hungary, 6Tolna County Teaching Hospital, Department of Gastroenterology, Szekszárd, Hungary, 7Markusovszky Hospital, Department of Medicine and Gastroenterology, Szombathely, Hungary, 8University of Debrecen, Institute of Medicine, Department of Gastroenterology, Debrecen, Hungary, 9University of Debrecen, Division of Gastroenterology, Department of Internal Medicine, Debrecen, Hungary, 10Pándy Kálmán Hospital of Békés County, Gyula, Hungary, 11Department of Medicine, Csolnoky F. Province Hospital, Veszprém, Hungary, 12Semmelweis University, First Department of Internal Medicine, Budapest, Hungary, 13Unversity of Pécs, Division of Gastroenterology, First Department of Medicine, Pécs, Hungary, 14University of Pécs, Second Department of Internal Medicine, Pécs, Hungary, 16Semmelweis University, First Deparment of Surgery, Budapest, Hungary, 17Buda Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary, 18University of Pécs, First Department of Internal Medicine, Pécs, Hungary

P535: Azathioprine vs. mesalamine for prevention of post-operative clinical relapse in Crohn’s disease patients with severe endoscopic recurrence: data on efficacy and safety from an IG-IBD multi-centre randomised double-blind double-dummy trial

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Orlando*1, F. Mocciaro2, M. Ventimiglia1, S. Renna1, D. Scimeca2, A. Rispo3, M. L. Scribano4, A. Testa3, A. Aratari5, F. Bossa6, E. Angelucci7, S. Onali8, M. Cappello9, M. Giunta10, F. Castiglione3, C. Papi5, V. Annese6, L. Biancone8, A. Kohn4, R. Di Mitri2, M. Cottone11

1IBD Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 2Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy, 3Department of Gastroenterology, Federico II University, Naples, Italy, 4Gastroenterology Unit, San Camillo Forlanini, Rome, Italy, 5Department of Gastroenterology, San Filippo Neri Hospital, Rome, Italy, 6Department of Gastroenterology, IRCCS, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG), Italy, 7Department of Gastroenterology, Sapienza University, Rome, Italy, 8Department of Gastroenterology, Tor Vergata University, Rome, Italy, 9Department of Gastroenterology, Palermo University, Palermo, Italy, 10Gastroenterology Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 11Internal Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy

P536: Thiopurine metabolite levels in pregnant IBD patients and infants following intrauterine thiopurine exposure

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Flanagan*1, A. Ross1, A. L. Hamilton1, S. J. Bell1

1St Vincent's Hospital, Gastroenterology, Melbourne, Australia

P537: The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Dulai*1, L. Peyrin-Biroulet2, K. Hahn3, N. Khalife4, D. Lindner5, K. Lasch6, D. Demuth7, H. Patel8, V. Jairath9

1University of California - San Diego, La Jolla, USA, 2Nancy University Hospital, Nancy, France, 3IQVIA, Cambridge, USA, 4IQVIA, London, UK, 5Takeda Pharmaceuticals International AG, Zurich, Switzerland, 6Takeda Pharmaceuticals USA, Inc., Deerfield, USA, 7Takeda International – UK Branch, London, UK, 8Takeda Pharmaceuticals International, Deerfield, USA, 9Western University, London, ON, Canada

P538: Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

Z. Shavit-Brunschwig1, O. Ledder1, G. Focht1, D. Urlep2, R. Lev-Tzion1, D. Marcus1, E. Broide3, A. Assa4, S. Hussey5, A. Yerushalmy-Feler6, A. Levine7, J. Markowitz8, C. Norden9, D. Turner*1

1Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem, Israel, 2Children's Hospital University Medical Centre, Department of Gastroenterology, Hepatology and Nutrition, Ljubljana, Slovenia, 3Assaf Harofeh Medical Center, The Kamila Gonczarowski Institute for Gastroenterology and Liver Diseases, Beer Yaakov, Israel, 4Schneider Children's Medical Center, The Institute of Gastroenterology, Nutrition and Liver Diseases, Petah Tikva, Israel, 5Our Lady's Children's Hospital, Crumlin, National Centre for Paediatric Gastroenterology, Dublin, Ireland, 6Tel Aviv Sourasky Medical Center, ‘Dana-Dwek’ Children's Hospital, Pediatric Gastroenterology, Liver and Nutrition Unit, Tel Aviv, Israel, 7Wolfson Medical Center, Pediatric Gastroenterology and Nutrition Unit, Holon, Israel, 8Cohen Children's Medical Center of NY, Division of Pediatric Gastroenterology and Nutrition, New York, USA, 9Hvidovre University Hospital, Department of Paediatrics, Hvidovre, Denmark

P539: Impact of a multi-disciplinary team meeting for managing inflammatory bowel disease patients: professional practice analysis based on 869 cases

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Del Arco1, P. Rivière1, F. Zerbib1, D. Laharie1, F. Poullenot1

1Bordeaux University Hospital, Gastroenterology and nutrition, Bordeaux, France

P540: Therapeutic drug monitoring in ustekinumab: which factors affect trough levels?

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Theeuwen*1, N. Provoost1, M. Koning1, A. Van der Meulen - de Jong1, D. J. A. Moes2, J. Maljaars1

1LUMC, Gastroenterology-Hepatology, Leiden, The Netherlands, 2LUMC, Department of Clinical Pharmacy and Toxicology, LEIDEN, The Netherlands

P541: Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Pugliese*1, M. Daperno2, G. Fiorino3, E. Savarino4, E. Mosso5, L. Biancone6, A. Testa7, L. Sarpi8, M. Cappello9, G. Bodini10, F. Caprioli11, S. Festa12, G. Laino13, G. Maconi14, S. Mazzuoli15, G. Mocci16, A. Sartini17, A. D'Amore18, S. Alivernini19, E. Gremese19, A. Armuzzi20

1Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore, OU IBD Presidio Columbus, Rome, Italy, 2A.O. Ordine Mauriziano, Gastroenterology Unit, Turin, Italy, 3Humanitas Research Hospital, IBD Center, Department of Gastroenterology, Rozzano, Italy, 4University of Padua, Gastroenterology Unit, Department Surgery, Oncology and Gastroenterology, Padua, Italy, 5General and Specialistic Medicine/Gastroenterology, Città della Salute e della Scienza di Torino, Turin, Italy, 6University of Rome Tor Vergata, Department of Systems Medicine, Gastroenterology, Rome, Italy, 7Federico II University, Gastroenterology, Naples, Italy, 8Gastroenterologia ed Endoscopia Digestiva Aziendale USL Umbria1, Perugia, Italy, 9Gastroenterology and Hepatology Section, DiBiMis, Palermo, Italy, 10University of Genoa, Gastrointestinal Unit, Department of Internal Medicine, Genoa, Italy, 11Department of Pathophysiology and Transplantation, University of Milan and Gastroenterology and Endoscopy Unit, IRCCS Cà Granda, IRCCS Policlinico Hospital, Milan, Italy, 12San Filippo Neri Hospital, IBD Unit, Rome, Italy, 13Department of New Technologies and Translational Research in Medicine and Surgery, Pisa, Italy, 14Luigi Sacco University Hospital, Gastroenterology and IBD Unit, Milan, Italy, 15San Nicola Pellegrino Hospital, Gastroenterology Unit, Trani, Italy, 16‘Brotzu’ Hospital, Division of Gastroenterology, Cagliari, Italy, 17University of Modena and Reggio Emilia, Department of Internal Medicine, Gastroenterology Unit, Modena, Italy, 18Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore, Department of Dermatology, Rome, Italy, 19Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore, Division of Rheumatology, Rome, Italy, 20OU IBD Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy

P542: Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Verstockt*1,2, C. Claeys1, G. Van Assche1,2, A. D'Hoore3, A. Wolthuis3, S. Vermeire1,2, M. Ferrante1,2

1University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2KU Leuven, Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium, 3University Hospitals Leuven, Department of Abdominal surgery, Leuven, Belgium

P543: Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Cassieri*1, R. Pica2, E. V. Avallone1, G. Brandimarte3, M. Zippi2, P. Crispino1, D. De Nitto2, P. G. Lecca3, P. Vernia1, P. Paoluzi1, E. S. Corazziari1

1Sapienza University, Internal Medicine and Medical Specialties, Rome, Italy, 2Sandro Pertini Hospital, Unit of Gastroenterology and Digestive Endoscopy, Rome, Italy, 3’Cristo Re’ Hospital, Internal Medicine, Rome, Italy

P544: Impact of patient education on switch acceptance in IBD patients in remission, with infliximab originator switched for an infliximab biosimilar: a prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Hastier-De Chelle*1, V. Cluzeau1, J. Condat1, N. Arab1, X. Hébuterne1, J. Filippi1

1Hôpital Archet 2, Alpes-Maritimes, Nice, France

P545: Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Porcari1, O. Fidanza1, A. Alibrandi2, S. Renna3, M. Cappello4, S. Siringo5, A. Privitera6, G. Inserra7, F. Mocciaro8, G. Magri9, A. Carroccio10, N. Belluardo11, C. Bertolami12, S. Garufi13, M. Ventimiglia3, F. Macaluso3, A. Viola1, M. Cottone15, A. Orlando3, W. Fries*16

1Inflammatory Bowel Disease Unit, A.O.U. Policlinico ‘G. Martino’, Messina, Italy, 2University of Messina, Department of Economics, Unit of Statistical and Mathematical Sciences, messina, Italy, 3Inflammatory bowel disease Unit, A.O.O.R. ‘Villa Sofia-Cervello’, Palermo, Italy, 4Gastroenterology and Hepatology Unit, A.O.U. Policlinico ‘G. Giaccone’, Palermo, Italy, 5Gastroenterology Unit, A.R.N.A.S. ‘Garibaldi’, Catania, Italy, 6Inflammatory Bowel Disease Unit, A.O. ‘Cannizzaro’, Catania, Italy, 7Internal Medicine Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy, 8Gastroenterology and Endoscopy Unit, A.R.N.A.S. ‘Civico Di Cristina Benfratelli’, Palermo, Italy, 9Gastroenterology Unit, A.O. ‘Santa Marta e S. Venera’, Acireale (CT), Italy, 10Internal Medicine Unit, A.O. ‘Giovanni Paolo II’, Sciacca (AG), Italy, 11Gastroenterology Unit, A.O. ‘Guzzardi’, Vittoria (RG), Italy, 12Gastroenterology Unit, A.O.O.R. ‘Papardo Piemonte’, Messina, Italy, 13Gastroenterology Unit, A.O.O.R. ‘S. Elia- M. Raimondi’, Caltanissetta, Italy, 15Inflammatory Bowel Disease Unit, A.O.O.R. ‘Villa Sofia-Cervello’, Messina, Italy, 16University of Messina, Department of Clinical and Experimental Medicine, Messina, Italy

P546: Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Torres1, D. Martín Arranz2, M. Sánchez Azofra2, E. Martín Arranz2, L. Garcia2, P. Nozal3, J. Pascual1, I. Apraiz1, M. López1, D. Arteta1, D. Nagore*1

1Progenika Biopharma, S.A, A Grifols company, Derio, Spain, 2Unidad de Enfermedad Inflamatoria Intestinal Hospital Universitario La Paz, Madrid, Spain, 3Unidad de Inmunología, Madrid, Spain

P547: Distribution of mesenteric macrophage polarisation: a guide for surgical resections in Crohn’s disease?

ECCO '19 Copenhagen

Year: 2019
Authors:

J. van der Meer*1, K. Wasmann2, J. van der Bilt3, M. Becker1, W. Bemelman2, M. Wildenberg1,4, C. Buskens2

1Amsterdam UMC, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands, 2Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands, 3Flevoziekenhuis, Department of Surgery, Almere, The Netherlands, 4Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P548: Vedolizumab clinical decision support tool predicts hospitalisation, surgery, and healthcare resource utilisation

ECCO '19 Copenhagen

Year: 2019
Authors:

P. S. Dulai*1, Z. Huang2, Y. Wan2, M. Luo2

1University of California San Diego, La Jolla, CA, USA, 2Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA

P549: Vitamin D deficiency as a part of extraintestinal manifestations in IBD Patients: a single-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Georgieva*1, A. Atanassova1, D. Gerova2, M. Todorova2

1Medical University Varna, Clinic of Hepatogastroenterology, St. Marina University Hospital, Vаrna, Bulgaria, 2Medical University Varna, Department of General Medicine and Clinical Laboratory, Varna, Bulgaria

P550: Anti-mycobacterium paratuberculous therapy in Crohn’s disease: outcomes from tertiary IBD referral centres

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Johnston*1, S. Honap1, B. Al-Hakim1, J. Sanderson1

1Guy's and St. Thomas' Hospitals NHS Foundation Trust, Gastroenterology, London, UK

P551: Use of preoperative total parenteral nutrition is associated with clinical and laboratory remission in severe active Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Kolonimos*1,2, M. S. Berns1,2, L. Hai Katvan1,2, M. Zelcer1,2, O. A. Hatoum2,3, N. Sakran2,3, I. M. Gralnek1,2, E. Zittan1,2

1HaEmek Medical Center, Ellen and Pinchas Mamber Institute of Gastroenterology and Liver Diseases and the Center for IBD, Afula, Israel, 2Technion-Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel, 3HaEmek Medical Center, Department of Surgery, Afula, Israel

P552: Gastroenterologists’ perceptions on use of medical cannabis for IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Koslowsky*1, A. Bar-Gil Shitrit1, E. Goldin1, B. Mazuz1

1Shaare-Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel